Upfront surgery (N = 22) Neoadjuvant chemotherapy (N = 22)
p
Resection margin status R0 resection R1 resection 19 (86.4%) 3 (13.6%) 16 (72.7%) 6 (27.3%)
0.268
Pathological findings PFH EMEF MEM SCU 2 (9.1%) 16 (72.7%) 2 (9.1%) 2 (9.1%) 5 (22.7%) 9 (40.9%) 8 (36.4%) 0 (0%)
0.031
Postoperative chemotherapy regimen C5V (2–4) PLADO (2–4) 13 (59.1%) 9 (40.9%) 14 (63.6%) 8 (36.4%)
0.77